Drawing for SORE THROAT FEVER CHEST CONGESTION COUGH NASAL CONGESTION SINUS CONGESTION SINUS PRESSURE HEADACHE BODY PAIN ALL IN ONE*

USPTO serial 88211687

SORE THROAT FEVER CHEST CONGESTION COUGH NASAL CONGESTION SINUS CONGESTION SINUS PRESSURE HEADACHE BODY PAIN ALL IN ONE*

Reviewed by CopyMark Law Group

Reg. 5832249Status 702Registered
Filing date
Status date
Registration date
Aug 13, 2019
Examiner
COGAN, BRITTNEY LORRAINE
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with SORE THROAT FEVER CHEST CONGESTION COUGH NASAL CONGESTION SINUS CONGESTION SINUS PRESSURE HEADACHE BODY PAIN ALL IN ONE*?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark Lerner, Esq.

Mark Lerner, Esq. DUANE MORRIS LLP230 PARK AVENUE, SUITE 1130NEW YORK, NY 10169United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; [ preparations for the treatment of respiratory and pulmonary conditions; ] expectorants; anti-pyretic preparations, namely, pharmaceutical preparations for reducing fever; decongestants; cough suppressant; pharmaceutical antitussive-cold preparations; preparations for treating colds [; allergy relief medication; antihistamines ]ACTIVEJul 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 1, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 1, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 1, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 16, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Aug 13, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 13, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 28, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 28, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 22, 2019ALIEASSIGNED TO LIE—
Apr 5, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 5, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 5, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 5, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 5, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 5, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 5, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 1, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 1, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2018GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Dec 21, 2018GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Dec 21, 2018EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Dec 21, 2018CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Dec 19, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 18, 2018DOCKASSIGNED TO EXAMINER—
Dec 18, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 4, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance